Marc J Weintraub1, Christopher D Schneck2, David A Axelson3, Boris Birmaher4, Robert A Kowatch3, David J Miklowitz5. 1. Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles. Electronic address: mjweintraub@mednet.ucla.edu. 2. School of Medicine, the University of Colorado, Aurora. 3. Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus. 4. University of Pittsburgh Medical Center, PA. 5. Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles.
Abstract
OBJECTIVE: The Course and Outcome of Bipolar Youth study found that children and adolescents with bipolar spectrum disorders followed 1 of 4 distinct mood trajectories over 8 years of follow-up, with as many as 25% of participants showing a predominantly euthymic course. We evaluated whether similar patterns of illness course are observed in adolescents with bipolar I and II disorder who participated in a 2-year clinical trial. METHOD: A total of 144 adolescents with bipolar I or II disorder, identified shortly after a mood episode, were assessed over a 2-year period. Participants were randomly assigned to one of 2 psychosocial family treatments during the first 9 months of the study, and pharmacotherapy was provided throughout the 2 years. Using latent class growth analyses, we classified participants into distinct courses of illness based on mood ratings collected over the 2 years. We examined demographic and illness variables as predictors of these course classifications. RESULTS: Latent class growth analyses indicated four mood trajectories: "predominantly euthymic" (29.9% of sample), "ill with significantly improving course" (11.1%), "moderately euthymic" (26.4%), and "ill with moderately improving course" (32.6%). Adolescents in these classes were euthymic 77.7%, 53.6%, 44.1%, and 18.6% of the weeks of follow-up, respectively. Psychosocial treatment condition and baseline medication exposure were not associated with trajectories. However, youth with more severe baseline depressive symptoms, suicidality, lower quality of life scores, and minority race/ethnicity had more symptomatic courses of illness over time. CONCLUSION: A substantial proportion (25%-30%) of youth with bipolar I or II disorder maintain euthymic states over extended periods of follow-up. Identifying youth who are more and less likely to remain stable over time may help guide psychosocial and pharmacological treatments after an illness episode. CLINICAL TRIAL REGISTRATION INFORMATION: Effectiveness of Family-Focused Treatment Plus Pharmacotherapy for Bipolar Disorder in Adolescents; https://clinicaltrials.gov/; NCT00332098.
OBJECTIVE: The Course and Outcome of Bipolar Youth study found that children and adolescents with bipolar spectrum disorders followed 1 of 4 distinct mood trajectories over 8 years of follow-up, with as many as 25% of participants showing a predominantly euthymic course. We evaluated whether similar patterns of illness course are observed in adolescents with bipolar I and II disorder who participated in a 2-year clinical trial. METHOD: A total of 144 adolescents with bipolar I or II disorder, identified shortly after a mood episode, were assessed over a 2-year period. Participants were randomly assigned to one of 2 psychosocial family treatments during the first 9 months of the study, and pharmacotherapy was provided throughout the 2 years. Using latent class growth analyses, we classified participants into distinct courses of illness based on mood ratings collected over the 2 years. We examined demographic and illness variables as predictors of these course classifications. RESULTS: Latent class growth analyses indicated four mood trajectories: "predominantly euthymic" (29.9% of sample), "ill with significantly improving course" (11.1%), "moderately euthymic" (26.4%), and "ill with moderately improving course" (32.6%). Adolescents in these classes were euthymic 77.7%, 53.6%, 44.1%, and 18.6% of the weeks of follow-up, respectively. Psychosocial treatment condition and baseline medication exposure were not associated with trajectories. However, youth with more severe baseline depressive symptoms, suicidality, lower quality of life scores, and minority race/ethnicity had more symptomatic courses of illness over time. CONCLUSION: A substantial proportion (25%-30%) of youth with bipolar I or II disorder maintain euthymic states over extended periods of follow-up. Identifying youth who are more and less likely to remain stable over time may help guide psychosocial and pharmacological treatments after an illness episode. CLINICAL TRIAL REGISTRATION INFORMATION: Effectiveness of Family-Focused Treatment Plus Pharmacotherapy for Bipolar Disorder in Adolescents; https://clinicaltrials.gov/; NCT00332098.
Authors: Robert A Kowatch; Mary Fristad; Boris Birmaher; Karen Dineen Wagner; Robert L Findling; Martha Hellander Journal: J Am Acad Child Adolesc Psychiatry Date: 2005-03 Impact factor: 8.829
Authors: Lena Nabuco de Abreu; Fabiano G Nery; Jill M Harkavy-Friedman; Karla Matias de Almeida; Bernardo Carramao Gomes; Maria A Oquendo; Beny Lafer Journal: Compr Psychiatry Date: 2011-05-06 Impact factor: 3.735
Authors: Roy H Perlis; Sachiko Miyahara; Lauren B Marangell; Stephen R Wisniewski; Michael Ostacher; Melissa P DelBello; Charles L Bowden; Gary S Sachs; Andrew A Nierenberg Journal: Biol Psychiatry Date: 2004-05-01 Impact factor: 13.382
Authors: Willem A Nolen; David A Luckenbaugh; Lori L Altshuler; Trisha Suppes; Susan L McElroy; Mark A Frye; Ralph W Kupka; Paul E Keck; Gabriele S Leverich; Robert M Post Journal: Am J Psychiatry Date: 2004-08 Impact factor: 18.112
Authors: Rasim S Diler; John A Merranko; Danella Hafeman; Tina R Goldstein; Benjamin I Goldstein; Heather Hower; Mary Kay Gill; David A Axelson; Neal Ryan; Michael Strober; Martin B Keller; Shirley Yen; Jeffrey I Hunt; Lauren M Weinstock; Satish Iyengar; Boris B Birmaher Journal: J Affect Disord Date: 2022-01-13 Impact factor: 4.839
Authors: Marc J Weintraub; Christopher D Schneck; Patricia D Walshaw; Kiki D Chang; Aimee E Sullivan; Manpreet K Singh; David J Miklowitz Journal: J Affect Disord Date: 2020-08-13 Impact factor: 4.839